Skip to content
Screener

Capricor Therapeutics CAPR Prepaid & Other Current

Prepaid & Other Current at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$105.78M-17.1%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$66.05M+15.8%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$7.11M-60.4%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$48.87M+307%
Cytokinetics logo
CytokineticsCYTK
$17.99M-10.0%
Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
$10.23M+50.6%

Other financials

Income statement

See full
Revenue--100%
Operating income-$36.8M-47.2%
Net income-$33.9M-39.2%
EPS (diluted)-$0.59-11.3%

Balance sheet

See full
Cash & equivalents$105.4M+266%
Total debt$14.8M+1,083%
Total equity$278.7M+118%
Total assets$326.3M+112%

Cash flow

See full
Operating cash flow-$29.3M-355%
CapEx$5.1M+472%
Free cash flow-$34.4M-369%

Valuation

See full
Market cap$236.86M-42.9%
Enterprise value$146.22M-62.7%

Profitability

See full
Operating margin-778.8%-1,038pp
Net margin-736.6%-981pp
FCF margin-563.9%-954pp

Returns & leverage

See full
Return on equity-56.4%-11.3pp
Debt / equity0.1×0.0×
Current ratio8.4×+1.9×

Where this comes from

Reported directly by Capricor Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 5:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-060382
Line itemMarch 31, 2026 / (unaudited)December 31, 2025December 31, 2025
Cash and cash equivalents$105,421,484$$287,847,312
Marketable securities173,188,43030,281,603
Receivables59,167
Prepaid expenses and other current assets4,478,8954,751,674
TOTAL CURRENT ASSETS283,088,809322,939,756
PROPERTY AND EQUIPMENT, net28,502,61718,312,238
OTHER ASSETS
Lease right-of-use assets, net13,158,50013,537,820

Item 1. Financial Statements.

FAQ

What is Capricor Therapeutics's prepaid & other current?
Capricor Therapeutics (CAPR) reported prepaid & other current of $4.48M in Q1 2026.
How has Capricor Therapeutics's prepaid & other current changed year-over-year?
Capricor Therapeutics's prepaid & other current increased by 216.8% year-over-year, from $1.41M to $4.48M.
What is the long-term trend for Capricor Therapeutics's prepaid & other current?
Over 5 years (2020 to 2025), Capricor Therapeutics's prepaid & other current has grown at a 36.3% compound annual growth rate (CAGR), from $1.01M to $4.75M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Capricor Therapeutics's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude